US
iShares Genomics Immunology and Healthcare ETF
IDNA · Equity
$29.98
+0.67%
Assets
n/a
Expense ratio
0.47%
Holdings
66
1Y return
+58.2%
Forward P/E
n/a
Top 10 holdings
+47.1%
Return and risk
| 1Y total return | +58.2% |
| 3Y total return | +27.6% |
| 5Y total return | -30.1% |
| 3Y CAGR | +8.5% |
| 5Y CAGR | -6.9% |
| Beta | 0.97 |
| RSI | 51.48 |
Fund structure
| Asset class | Equity |
| Assets | n/a |
| Holdings | 66 |
| Expense ratio | 0.47% |
| Dividend yield | +1.0% |
| Top 10 holdings | +47.1% |
| Volume | 47.3K |
All ETF indicators
| All Time High | 55.55 |
| All Time High Change | -46.14 |
| All Time High Date | 2021-09-07 |
| All Time Low | 17.26 |
| All Time Low Change | 73.35 |
| All Time Low Date | 2025-04-09 |
| Atr | 0.61 |
| Beta | 0.97 |
| Cagr1y | 58.27 |
| Cagr3y | 8.46 |
| Cagr5y | -6.91 |
| Ch1m | 2.05 |
| Ch1w | 0.91 |
| Ch1y | 56.16 |
| Ch3m | 3.35 |
| Ch3y | 23.48 |
| Ch5y | -33.11 |
| Ch6m | 14.72 |
| Ch YTD | 14.24 |
| Close | 29.78 |
| Div CAGR3 | 63.33 |
| Div CAGR5 | 20.8 |
| Dividend Growth | 38.6 |
| Dividend Growth Years | 1 |
| Dividend Years | 7 |
| Dividend Yield | 1.03 |
| Dps | 0.31 |
| Ex Div Date | 2025-12-16 |
| High52 | 31.41 |
| High52ch | -4.55 |
| High52 Date | 2026-04-17 |
| Inception Date | 2019-06-11 |
| Isin | US46435U1925 |
| Last Dividend | 0.16 |
| Low52 | 19.11 |
| Low52ch | 56.88 |
| Low52 Date | 2025-05-14 |
| Ma150 | 27.91 |
| Ma150ch | 7.21 |
| Ma20 | 30.07 |
| Ma200 | 26.57 |
| Ma200ch | 12.61 |
| Ma20ch | -0.5 |
| Ma50 | 29.57 |
| Ma50ch | 1.19 |
| Payment Date | 2025-12-19 |
| Payout Frequency | Semi-Annual |
| Payout Ratio | 14.63 |
| Price Date | 2026-05-12 |
| Rsi | 51.48 |
| Rsi Monthly | 62.12 |
| Rsi Weekly | 58.68 |
| Sharpe Ratio | 1.83 |
| Sortino Ratio | 3.23 |
| Top10holdings | 47.15 |
| Tr1m | 2.05 |
| Tr1y | 58.22 |
| Tr3m | 3.35 |
| Tr3y | 27.61 |
| Tr5y | -30.07 |
| Tr6m | 15.4 |
| Tr YTD | 14.24 |